STOCK TITAN
  1. Home
  2. News
  3. AVRW

AVENIR WELLNESS SOLUTION - $AVRW STOCK NEWS

Welcome to our dedicated page for AVENIR WELLNESS SOLUTION news (Ticker: $AVRW), a resource for investors and traders seeking the latest updates and insights on AVENIR WELLNESS SOLUTION stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AVENIR WELLNESS SOLUTION's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AVENIR WELLNESS SOLUTION's position in the market.

News
Avenir Wellness Solutions Issues 2024 Marketing Growth Plans to Shareholders for Seratopical Revolution Skin Care Line with Support from Nicole Kidman and Facial Plastic Surgeon Dr. Michael Persky
Rhea-AI Summary
Avenir Wellness Solutions announces 2024 marketing growth plans for Seratopical Revolution skin care line with support from Nicole Kidman and Dr. Michael Persky. The company plans to launch a new TikTok Shop to enhance brand awareness and product sales. With endorsements from Nicole Kidman and Dr. Persky, Avenir is set for a growth year in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15%
Tags
none
-
News
Avenir Wellness Solutions Announces Return of Stock Trading Back to OTCQB Market
Rhea-AI Summary
Avenir Wellness Solutions, Inc. (OTCQB:AVRW) announces the trading of its common stock has been moved back to the OTCQB market, effective September 15, 2023. The move removes trading limitations and benefits shareholders. The company's finance team and Urish Popeck worked diligently to complete filings and meet compliance deadlines.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.18%
Tags
none
-
News
The Sera Labs, Inc. Announces Partnership With LA-Based Facial Plastic Surgeon Dr. Michael Persky to Support Latest DNA Complex Product Launch
Rhea-AI Summary
Renowned plastic surgeon Dr. Michael Persky joins Sera Labs as a member of the Medical Advisory Board to support marketing for the brand's latest launches and advise on new product innovation. Dr. Persky will help promote the brand's DNA Complex, an instant anti-aging skin tightening serum. The consumer response and demand for DNA Complex have been overwhelmingly positive. The product retails at $99.99.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.09%
Tags
partnership
News
Avenir Wellness Solutions Reports Second Quarter 2023 Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
50%
Tags
earnings
Stock AVRW logo
AVENIR WELLNESS SOLUTION

OTC:AVRW

AVRW Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

AVRW Stock Data

2.34M
50.30M
32.99%
0.08%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Sherman Oaks

About AVRW

cure pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. cure has an industry leading full-service cgmp manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (curefilm™), the most advanced oral thin film on the market today. cure has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. cure has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the u.s., canada, israel and germany, among other markets. our mission is to improve people's lives by redefining how medicines are delivered and experienced.